BMS 140 857 (Sprycel 140 mg)

Generic Name: dasatinib

Pill with imprint BMS 140 857 is White, Round and has been identified as Sprycel 140 mg. It is supplied by Bristol-Myers Squibb.

Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 140 857

Save up to 80% off prescription medications

Click here for your free Discount Card

Sprycel

Generic Name

dasatinib

Imprint

BMS 140 857

Strength

140 mg

Color

White

Size

11.00 mm

Shape

Round

Availability

Prescription only

Drug Class

BCR-ABL tyrosine kinase inhibitors

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Bristol-Myers Squibb

National Drug Code (NDC)

00003-0857

Inactive Ingredients

lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, titanium dioxide

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer